Menu
Back to User profile » Prof. Dr. Kai-Chun Cheng
Papers published by Prof. Dr. Kai-Chun Cheng:
Promotion of Adropin Expression by Hyperglycemia Is Associated with STAT3 Activation in Diabetic Rats
Kuo FY, Cheng KC, Li Y, Cheng JT, Tsai CC
Diabetes, Metabolic Syndrome and Obesity 2020, 13:2269-2277
Published Date: 29 June 2020
Telmisartan is effective to ameliorate metabolic syndrome in rat model – a preclinical report
Cheng KC, Li Y, Chang WT, Kuo FY, Chen ZC, Cheng JT
Diabetes, Metabolic Syndrome and Obesity 2018, 11:901-911
Published Date: 7 December 2018
Investigation of triamterene as an inhibitor of the TGR5 receptor: identification in cells and animals
Li Y, Cheng KC, Niu C, Lo S, Cheng JT, Niu H
Drug Design, Development and Therapy 2017, 11:1127-1134
Published Date: 5 April 2017
Development of betulinic acid as an agonist of TGR5 receptor using a new in vitro assay
Lo SH, Cheng KC, Li YX, Chang CH, Cheng JT, Lee KS
Drug Design, Development and Therapy 2016, 10:2669-2676
Published Date: 22 August 2016
Rosmarinic acid ameliorates hyperglycemia and insulin sensitivity in diabetic rats, potentially by modulating the expression of PEPCK and GLUT4
Runtuwene J, Cheng KC, Asakawa A, Amitani H, Amitani M, Morinaga A, Takimoto Y, Kairupan BHR, Inui A
Drug Design, Development and Therapy 2016, 10:2193-2202
Published Date: 7 July 2016